LOGO.png
Nemaura Medical to Present at the Benzinga Global Small Cap Conference
November 30, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
LOGO.png
Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update
November 15, 2021 09:30 ET | Nemaura Medical, Inc
Loughborough, England, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical to Present at the Diabetes Technology Society 2021 Conference on November 4, 2021
November 03, 2021 18:51 ET | Nemaura Medical, Inc
Loughborough, England, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
LOGO.png
Nemaura Medical to Present at the LD Micro Main Event Conference
October 05, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
LOGO.png
Nemaura Medical Launches Beta Version of Its Metabolic Health Program
September 29, 2021 08:30 ET | Nemaura Medical, Inc
MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England, Sept. 29, 2021 (GLOBE...
LOGO.png
Nemaura Medical Announces Commercial Agreement with UK Licensee
September 27, 2021 08:00 ET | Nemaura Medical, Inc
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura”...
nmrd.jpg
Nemaura Medical Inc. (NASDAQ: NMRD) Diabetes, Obesity Solutions Differentiated in Form and Function
September 24, 2021 08:30 ET | Nemaura Medical Inc.
NEW YORK, Sept. 24, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio -- Nemaura Medical Inc. (NASDAQ: NMRD)  announces the availability of a broadcast titled, “Healthcare Technologies Spearheading Modern...
nmrd.jpg
Nemaura Medical Inc. (NASDAQ: NMRD) Offers Sought-After Solutions in Areas of Unmet Medical Need
September 22, 2021 08:30 ET | Nemaura Medical Inc.
NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Nemaura Medical Inc. (NASDAQ: NMRD) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+...
LOGO.png
Nemaura Medical to Present at the Benzinga Healthcare Small Cap Conference
September 21, 2021 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable...
LOGO.png
Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021
August 16, 2021 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...